Claim by GlaxoSmithKline UK Limited for revocation and a declaration of non-infringement in respect of a patent.
Held: The challenges to the validity of the patent failed.
Henry Carr J
[2016] EWHC 1045 (Ch)
Bailii
England and Wales
Intellectual Property
Updated: 16 January 2022; Ref: scu.564149